|
PTGX Protagonist Therapeutics Inc 1377121 |
| Balance Sheet |
|
Current Assets
|
$807,148,000.00 |
|
Assets
|
$885,544,000.00 |
|
Current Liabilities
|
$37,181,000.00 |
|
Liabilities
|
$44,001,000.00 |
|
Equity
|
$841,543,000.00 |
|
Shares Out
|
64672032.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$170,109,000.00 |
|
Investing Cash Flow
|
$88,462,000.00 |
| Market Analysis |
Market Cap
|
$9,745,428,502.08 |
|
Price
|
$150.69 |
|
BVPS
|
13.01 |
|
PB
|
11.58 |
|
EPS
|
2.47 |
|
PS
|
43.22 |
|
FCF
|
$169,726,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:21 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:12 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-25 |
-0.69 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-05 |
0.05 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
-0.55 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.62 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PTGX documents filed with the SEC.
PTGX Filings
Clear
